Results 11 to 20 of about 21,604,258 (289)
Chimeric Antigen Receptor T Cell Therapy in Hematology
It is well demonstrated that the immune system can control and eliminate cancer cells. Immune-mediated elimination of tumor cells has been discovered and is the basis of both cancer vaccines and cellular therapies including hematopoietic stem cell ...
Pınar Ataca, Önder Arslan
doaj +4 more sources
Chimeric antigen receptor T cell therapy for multiple myeloma [PDF]
Chimeric antigen receptor (CAR) T cell therapy is a new cancer immunotherapy targeting cancer-specific cell surface antigen. CD19-CAR T cells have been already shown to be very effective to B cell leukemia/lymphoma.
Kana Hasegawa, Naoki Hosen
doaj +7 more sources
Chimeric Antigen Receptor T Cell Therapy For Solid Tumors
Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the management of lymphoid malignancies. However, it is still in its early phase and is facing many obstacles in solid tumors.
Jingmei Hsu +5 more
doaj +4 more sources
Chimeric Antigen Receptor-T-Cell Therapy
Although treatment of haematological cancer has improved significantly during the latest decades, the prognosis is poor in case of relapse or refractory disease.
Deniz GÖREN ŞAHİN, Olga Meltem AKAY
core +10 more sources
Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas [PDF]
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell ...
Bei Hu +3 more
doaj +2 more sources
Chimeric antigen receptor T-cell therapy [PDF]
Although treatment of haematological cancer has improved significantly during the latest decades, the prognosis is poor in case of relapse or refractory disease. This review describes the chimeric antigen receptor (CAR) T-cell therapy, which has emerged as a new promising treatment principle, in which the patient's own T-cells are genetically modified ...
Azgar Abdul Rasheed +1 more
+6 more sources
CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
Chimeric antigen receptor (CAR) T-cell therapy constitutes a revolutionary advancement in personalized cancer treatment. During this treatment, a patient's own T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen.
BOT ADRIAN, MATTIE MICHAEL DAVID
+12 more sources
Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy
Chimeric antigen receptor T‐cell (CAR‐T) therapy is becoming an effective technique for the treatment of patients with relapsed/refractory hematologic malignancies.
Delian Zhou, Xiaojian Zhu, Yi Xiao
doaj +2 more sources
Genome Editing as a Vehicle to Drive Successful Chimeric Antigen Receptor T Cell Therapies to the Clinic [PDF]
Chimeric antigen receptor (CAR) T cells have emerged as an effective therapy for patients with relapsed and refractory haematological malignancies. However, there are many challenges preventing clinical efficacy and thus broader translation of this ...
Caitlin R Hopkins, Joseph A Fraietta
core +1 more source
Experimental and Clinical Pharmacology: Chimeric antigen receptor T-cell therapy
Chimeric antigen receptor T-cell therapies are promising new options for patients with relapsed or refractory diffuse large B-cell lymphoma or acute lymphoblastic leukaemia. They increase complete response rates and the chances of achieving prolonged remission.
Burge, Cale +2 more
openaire +2 more sources

